YOUR HEALTH. A MORE INFORMED VIEW.
Urinary organisms and selected resistance genes.
CLINICAL AUTHORDr Nirupama SabhapathySpecialist Clinical Pathology
THE PURPOSE BEHIND THE PANEL.
Thirty-one listed analytes combine organism targets and resistance markers in a urine molecular panel.
19named targets19 listed entries
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
12named targets12 listed entries
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
1laboratory assay1 included assay
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase.
The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
The 31-analyte count includes both organisms and selected resistance genes. A resistance gene is not a separate infection or a complete antibiotic-susceptibility result.
31 named target entries · 1 included assay · 31 Analytes
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Looks for listed urinary organisms and selected resistance genes. Gene detection is not a full antibiotic-susceptibility result or a treatment prescription.
INCLUDED COMPONENTS
Try a test or target name, or choose another health focus.
Checking a prescription?
Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
Choose the investigation around the question you want to discuss. The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
Thirty-one listed analytes combine organism targets and resistance markers in a urine molecular panel.
Compare the full included list with your clinician’s request. The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
Preparation follows the actual specimen and tests in UTI Master 31. Confirm your personal instructions before collection.
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Across DubaiTHE LABORATORY. READY TO WELCOME YOU.
Intel Lab · Deira
101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
DEIRA · DUBAI101–102Al Hawai Building
Al Rigga Road
FROM BOOKING TO UNDERSTANDING.
Follow UTI Master 31 from your care bag to an informed conversation.
The right package. The right person.
Add UTI Master 31 to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Confirm the instructions for urine and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Intel Lab processes the sample and checks the report. The package lists 48 hours; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
UNDERSTANDING YOUR REPORTUrine
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 19 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
UNDERSTANDING YOUR REPORTUrine
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
UNDERSTANDING YOUR REPORTUrine
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase. The analyte count includes genes as well as organisms. This is not a complete antimicrobial-susceptibility profile and does not automatically prove a symptomatic UTI.
THE NEXT STEP IS PERSONAL.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
Review urinary organisms and any resistance-gene findings with symptoms and the specimen context. Selected genes are not a complete susceptibility result; the clinician may request culture or other follow-up before treatment decisions.
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
THE LABORATORY BEHIND YOUR RESULTS.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
EXPERTISE WITH A NAME.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Clinical reviewer
Specialist Clinical Pathology · Intel Lab
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
CHOOSE BY PURPOSE, NOT JUST COUNT.
Related packages may ask different questions. Compare their actual scope and discuss which, if any, is appropriate for you.
You are viewingA urine PCR panel with 19 organism targets and 12 selected resistance genes. Detection needs clinical interpretation and is not a complete antibiotic-susceptibility result.
A confidential 5-in-1 blood screen for the core blood-borne STIs: HIV (1 & 2), hepatitis B, hepatitis C and syphilis.
A 20-marker combined work-up pairing blood serology (HIV, hepatitis B & C, syphilis) with a 14-target genital PCR panel and urinalysis: a complete…
Our most comprehensive 28-target STI and genital-flora PCR panel, adding candida species, bacterial-vaginosis organisms and additional viruses on top…
Choosing for a particular need?
We can help you read the options.
BEFORE YOU BOOK.
Preparation, sample types, timing and what the package does—and does not—include.
Urinary organisms and selected resistance genes. The full named inventory on this page is the scope of the package.
No. Some entries are resistance genes rather than organisms. The report needs the clinical history and specimen context to determine what is relevant.
Not by itself. Symptoms, the specimen, the organism and other findings determine clinical relevance.
No. The listed genes are selected molecular markers. Their presence or absence does not describe susceptibility to every antibiotic.
No. The clinical question and exposure site may require an additional or different specimen.
Use the labelled sterile container and confirm handling, collection and transport timing. Tell the team if collection instructions could not be followed.
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
The package price is AED 999; the listed turnaround is 48 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
UTI Master 31 · 31 Analytes · Urine